Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

References

• HafnerHNowotnyBEpidemiology of early-onset schizophreniaEur Arch Psychiatry Clin Neurosci199524580927654792
   PubMed Web of Science ®Google Scholar
• MaziadeMGingrasNRodrigueCLong-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onsetBr J Psychiatry199616933613708879724
   PubMed Web of Science ®Google Scholar
• ThomsenPHSchizophrenia with childhood and adolescent onset – a nationwide register-based studyActa Psychiatr Scand19969431871938891086
   PubMed Web of Science ®Google Scholar
• SchimmelmannBGConusPCottonSMcGorryPDLambertMPretreatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patientsSchizophr Res200795131817628441
   PubMed Web of Science ®Google Scholar
• LuomaSHakkoHOllinenTJarvelinMRLindemanSAssociation between age at onset and clinical features of schizophrenia: the Northern Finland 1966 birth cohort studyEur Psychiatry200823533133518455370
   PubMed Web of Science ®Google Scholar
• HafnerHRiecherAMaurerKLofflerWMunk-JorgensenPStromgrenEHow does gender influence age at first hospitalization for schizophrenia? A transnational case register studyPsychol Med19891949039182594886
   PubMed Web of Science ®Google Scholar
• RemschmidtHESchulzEMartinMWarnkeATrottGEChildhood-onset schizophrenia: history of the concept and recent studiesSchizophr Bull19942047277457701279
   PubMed Web of Science ®Google Scholar
• RussellATThe clinical presentation of childhood-onset schizophreniaSchizophr Bull19942046316467701273
   PubMed Web of Science ®Google Scholar
• SpencerEKCampbellMChildren with schizophrenia: diagnosis, phenomenology, and pharmacotherapySchizophr Bull19942047137257701278
   PubMed Web of Science ®Google Scholar
• WerryJSMcClellanJMAndrewsLKHamMClinical features and outcome of child and adolescent schizophreniaSchizophr Bull19942046196307701272
   PubMed Web of Science ®Google Scholar
• SchaefferJLRossRGChildhood-onset schizophrenia: premorbid and prodromal diagnostic and treatment historiesJ Am Acad Child Adolesc Psychiatry200241553854512014786
   PubMed Web of Science ®Google Scholar
• EggersCBunkDThe long-term course of childhood-onset schizophrenia: a 42-year followupSchizophr Bull1997231051179050117
   PubMed Web of Science ®Google Scholar
• RopckeBEggersCEarly-onset schizophrenia: a 15-year follow-upEur Child Adolesc Psychiatry200514634135016220219
   PubMed Web of Science ®Google Scholar
• BassoMRNasrallahHAOlsonSCBornsteinRACognitive deficits distinguish patients with adolescent- and adult- onset schizophreniaNeuropsychiatry Neuropsychol Behav Neurol19971021071129150511
   PubMedGoogle Scholar
• GieddJNJeffriesNOBlumenthalJChildhood-onset schizophrenia: progressive brain changes during adolescenceBiol Psychiatry199946789289810509172
   PubMed Web of Science ®Google Scholar
• Tuulio-HenrikssonAPartonenTSuvisaariJHaukkaJLonnqvistJAge at onset and cognitive functioning in schizophreniaBr J Psychiatry200418521521915339825
   PubMed Web of Science ®Google Scholar
• BiswasPMalhotraSMalhotraAGuptaNComparative study of neuropsychological correlates in schizophrenia with onset in childhood, adolescence and adulthoodEur Child Adolesc Psychiatry200615636036616604435
   PubMed Web of Science ®Google Scholar
• FrazierJAMcClellanJFindlingRLTreatment of early- onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristicsJ Am Acad Child Adolesc Psychiatry200746897998817667477
   PubMed Web of Science ®Google Scholar
• JarbinHOttYVon KnorringALAdult outcome of social function in adolescent-onset schizophrenia and affective psychosisJ Am Acad Child Adolesc Psychiatry200342217618312544177
   PubMed Web of Science ®Google Scholar
• FleischhakerCSchulzETepperKMartinMHennighausenKRemschmidtHLong-term course of adolescent schizophreniaSchizophr Bull200531376978016123530
   PubMed Web of Science ®Google Scholar
• RemschmidtHMartinMFleischhakerCForty-two-years later: the outcome of childhood-onset schizophreniaJ Neural Transm2007114450551216897595
   PubMed Web of Science ®Google Scholar
• SikichLFindlingRSchluzSIndividual and school-based interventionsSchizophrenia in Adolescents and Children: Assessment, Neurobiology and TreatmentBaltimore (MD)John Hopkins University Press2005257287
   Google Scholar
• PoolDBloomWMielkeDHRonigerJJJrGallantDMA controlled evaluation of loxitane in seventy-five adolescent schizophrenic patientsCurr Ther Res Clin Exp197619199104812671
   PubMed Web of Science ®Google Scholar
• RealmutoGMEricksonWDYellinAMHopwoodJHGreenbergLMClinical comparison of thiothixene and thioridazine in schizophrenic adolescentsAm J Psychiatry19841414404426367494
   PubMed Web of Science ®Google Scholar
• KeepersGAClappisonVJCaseyDEInitial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromesArch Gen Psychiatry19834010111311176138011
   PubMed Web of Science ®Google Scholar
• KumraSFrazierJAJacobsenLKChildhood-onset schizophrenia. A double-blind clozapine-haloperidol comparisonArch Gen Psychiatry19965312109010978956674
   PubMed Web of Science ®Google Scholar
• LiebermanJATollefsonGTohenMComparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidolAm J Psychiatry200316081396140412900300
   PubMed Web of Science ®Google Scholar
• GreenAILiebermanJAHamerRMOlanzapine and haloperidol in first episode psychosis: two-year dataSchizophr Res2006861323424316842972
   PubMed Web of Science ®Google Scholar
• LiebermanJAStroupTSMcEvoyJPEffectiveness of antipsychotic drugs in patients with chronic schizophreniaN Engl J Med2005353121209122316172203
   PubMed Web of Science ®Google Scholar
• SikichLHamerRMBashfordRASheitmanBBLiebermanJAA pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trialNeuropsychopharmacology200429113314514583740
   PubMed Web of Science ®Google Scholar
• SikichLFrazierJAMcClellanJDouble-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) studyAm J Psychiatry2008165111420143118794207
   PubMed Web of Science ®Google Scholar
• BeesdoKHoflerMLeibenluftELiebRBauerMPfennigAMood episodes and mood disorders: patterns of incidence and conversion in the first three decades of lifeBipolar Disord200911663764919689506
   PubMed Web of Science ®Google Scholar
• MerikangasKRAkiskalHSAngstJLifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replicationArch Gen Psychiatry200764554355217485606
   PubMed Web of Science ®Google Scholar
• PerlisRHDennehyEBMiklowitzDJRetrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD studyBipolar Disord200911439140019500092
   PubMed Web of Science ®Google Scholar
• OedegaardKJSyrstadVEMorkenGAkiskalHSFasmerOBA study of age at onset and affective temperaments in a Norwegian sample of patients with mood disordersJ Affect Disord20091181322923319246102
   PubMed Web of Science ®Google Scholar
• MorenoCLajeGBlancoCJiangHSchmidtABOlfsonMNational trends in the outpatient diagnosis and treatment of bipolar disorder in youthArch Gen Psychiatry20076491032103917768268
   PubMed Web of Science ®Google Scholar
• YoungstromEABirmaherBFindlingRLPediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosisBipolar Disord2008101 Pt 219421418199237
   PubMed Web of Science ®Google Scholar
• GellerBTillmanRBolhofnerKProposed definitions of bipolar I disorder episodes and daily rapid cycling phenomena in preschoolers, school-aged children, adolescents, and adultsJ Child Adolesc Psychopharmacol200717221722217489716
   PubMed Web of Science ®Google Scholar
• TillmanRGellerBDefinitions of rapid, ultrarapid, and ultradian cycling and of episode duration in pediatric and adult bipolar disorders: a proposal to distinguish episodes from cyclesJ Child Adolesc Psychopharmacol200313326727114642014
   PubMed Web of Science ®Google Scholar
• BirmaherBAxelsonDStroberMComparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disordersBipolar Disord2009111526219133966
   PubMed Web of Science ®Google Scholar
• LeibenluftECharneyDSTowbinKEBhangooRKPineDSDefining clinical phenotypes of juvenile maniaAm J Psychiatry2003160343043712611821
   PubMed Web of Science ®Google Scholar
• GellerBTillmanRCraneyJLBolhofnerKFour-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotypeArch Gen Psychiatry200461545946715123490
   PubMed Web of Science ®Google Scholar
• BirmaherBAxelsonDCourse and outcome of bipolar spectrum disorder in children and adolescents: a review of the existing literatureDev Psychopathol20061841023103517064427
   PubMed Web of Science ®Google Scholar
• RendeRBirmaherBAxelsonDPsychotic symptoms in pediatric bipolar disorder and family history of psychiatric illnessJ Affect Disord2006961212713116844230
   PubMed Web of Science ®Google Scholar
• StroberMBirmaherBRyanNPediatric bipolar disease: current and future perspectives for study of its long-term course and treatmentBipolar Disord20068431132116879132
   PubMed Web of Science ®Google Scholar
• DelBelloMPHansemanDAdlerCMFleckDEStrakowskiSMTwelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episodeAm J Psychiatry2007164458259017403971
   PubMed Web of Science ®Google Scholar
• LewinsohnPSeeleyJKleinDGellerBDelBelloMPBipolar disorder in adolescents: epidemiology and suicidal behaviorBipolar Disorder in Childhood and Early AdolescenceNew YorkGuilford2003724
   Google Scholar
• AxelsonDBirmaherBStroberMPhenomenology of children and adolescents with bipolar spectrum disordersArch Gen Psychiatry200663101139114817015816
   PubMed Web of Science ®Google Scholar
• CaetanoSCOlveraRLHunterKAssociation of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patientsJ Affect Disord2006911333716445989
   PubMed Web of Science ®Google Scholar
• GellerBCooperTBSunKDouble-blind and placebocontrolled study of lithium for adolescent bipolar disorders with secondary substance dependencyJ Am Acad Child Adolesc Psychiatry19983721711789473913
   PubMed Web of Science ®Google Scholar
• KafantarisVColettiDJDickerRPadulaGKaneJMLithium treatment of acute mania in adolescents: a large open trialJ Am Acad Child Adolesc Psychiatry20034291038104512960703
   PubMed Web of Science ®Google Scholar
• KafantarisVColettiDJDickerRPadulaGPleakRRAlvirJMLithium treatment of acute mania in adolescents: a placebo-controlled discontinuation studyJ Am Acad Child Adolesc Psychiatry200443898499315266193
   PubMed Web of Science ®Google Scholar
• KafantarisVColettiDJDickerRPadulaGKaneJMAdjunctive antipsychotic treatment of adolescents with bipolar psychosisJ Am Acad Child Adolesc Psychiatry200140121448145611765291
   PubMed Web of Science ®Google Scholar
• WagnerKDWellerEBCarlsonGAAn open-label trial of divalproex in children and adolescents with bipolar disorderJ Am Acad Child Adolesc Psychiatry200241101224123012364844
   PubMed Web of Science ®Google Scholar
• PavuluriMNHenryDBCarbrayJANaylorMWJanicakPGDivalproex sodium for pediatric mixed mania: a 6-month prospective trialBipolar Disord20057326627315898964
   PubMed Web of Science ®Google Scholar
• KowatchRASuppesTCarmodyTJEffect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorderJ Am Acad Child Adolesc Psychiatry200039671372010846305
   PubMed Web of Science ®Google Scholar
• FindlingRLMcNamaraNKGraciousBLCombination lithium and divalproex sodium in pediatric bipolarityJ Am Acad Child Adolesc Psychiatry200342889590112874490
   PubMed Web of Science ®Google Scholar
• WagnerKDKowatchRAEmslieGJA double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescentsAm J Psychiatry200616371179118616816222
   PubMed Web of Science ®Google Scholar
• WagnerKDReddenLKowatchRAA double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescentsJ Am Acad Child Adolesc Psychiatry200948551953219325497
   PubMed Web of Science ®Google Scholar
• PavuluriMNHenryDBCarbrayJASampsonGNaylorMWJanicakPGOpen-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric maniaJ Affect Disord200482Suppl 1S10311115571784
   PubMed Web of Science ®Google Scholar
• DelbelloMPSchwiersMLRosenbergHLStrakowskiSMA double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent maniaJ Am Acad Child Adolesc Psychiatry200241101216122312364843
   PubMed Web of Science ®Google Scholar
• FrazierJABiedermanJTohenMA prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorderJ Child Adolesc Psychopharmacol200111323925011642474
   PubMed Web of Science ®Google Scholar
• BarzmanDHDelBelloMPAdlerCMStanfordKEStrakowskiSMThe efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s)J Child Adolesc Psychopharmacol200616666567017201610
   PubMed Web of Science ®Google Scholar
• TohenMKryzhanovskayaLCarlsonGOlanzapine versus placebo in the treatment of adolescents with bipolar maniaAm J Psychiatry2007164101547155617898346
   PubMed Web of Science ®Google Scholar
• FindlingRLNyilasMForbesRAAcute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled studyJ Clin Psychiatry200970101441145119906348
   PubMed Web of Science ®Google Scholar
• HaasMDelbelloMPPandinaGRisperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled studyBipolar Disord200911768770019839994
   PubMed Web of Science ®Google Scholar
• FDA_website fda.gov/downloads/Drugs/DevelopmentApprovalProcess?DevelopmentResources/UCM163241.pdf. Published 2007Accessed Sep 15, 2009
   Google Scholar
• YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry1978133429435728692
   PubMed Web of Science ®Google Scholar
• DelBelloMPChangKWelgeJAA double-blind, placebocontrolled pilot study of quetiapine for depressed adolescents with bipolar disorderBipolar Disord200911548349319624387
   PubMed Web of Science ®Google Scholar
• BymasterFPCalligaroDOFalconeJFRadioreceptor binding profile of the atypical antipsychotic olanzapineNeuropsychopharmacology199614287968822531
   PubMed Web of Science ®Google Scholar
• FumagalliFFrascaASpartaMDragoFRacagniGRivaMALongterm exposure to the atypical antipsychotic olanzapine differently upregulates extracellular signal-regulated kinases 1 and 2 phosphorylation in subcellular compartments of rat prefrontal cortexMol Pharmacol20066941366137216391238
   PubMed Web of Science ®Google Scholar
• WirshingDAWirshingWCKysarLNovel antipsychotics: comparison of weight gain liabilitiesJ Clin Psychiatry199960635836310401912
   PubMed Web of Science ®Google Scholar
• KroezeWKHufeisenSJPopadakBAH1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugsNeuropsychopharmacology200328351952612629531
   PubMed Web of Science ®Google Scholar
• TemplemanLAReynoldsGPArranzBSanLPolymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosisPharmacogenet Genomics200515419520015864111
   PubMedGoogle Scholar
• UjikeHNomuraAMoritaYMultiple genetic factors in olanzapine- induced weight gain in schizophrenia patients: a cohort studyJ Clin Psychiatry20086991416142219193342
   PubMed Web of Science ®Google Scholar
• GunesAMelkerssonKIScordoMGDahlMLAssociation between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapineJ Clin Psychopharmacol2009291656819142110
   PubMed Web of Science ®Google Scholar
• KassahunKMattiuzENyhartEJrDisposition and biotransformation of the antipsychotic agent olanzapine in humansDrug Metab Dispos199725181939010634
   PubMed Web of Science ®Google Scholar
• KandoJCShepskiJCSatterleeWPatelJKReamsSGGreenAIOlanzapine: a new antipsychotic agent with efficacy in the management of schizophreniaAnn Pharmacother19973111132513349391688
   PubMed Web of Science ®Google Scholar
• LucasRAGilfillanDJBergstromRFA pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanismEur J Clin Pharmacol19985486396439860152
   PubMed Web of Science ®Google Scholar
• CallaghanJTBergstromRFPtakLRBeasleyCMOlanzapine. Pharmacokinetic and pharmacodynamic profileClin Pharmacokinet199937317719310511917
   PubMed Web of Science ®Google Scholar
• KellyDLConleyRRTammingaCADifferential olanzapine plasma concentrations by sex in a fixed-dose studySchizophr Res199940210110410593449
   PubMed Web of Science ®Google Scholar
• HiemkeCPeledAJabarinMFluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effectsJ Clin Psychopharmacol200222550250612352274
   PubMed Web of Science ®Google Scholar
• KroonLADrug interactions with smokingAm J Health Syst Pharm200764181917192117823102
   PubMed Web of Science ®Google Scholar
• SpinaEde LeonJMetabolic drug interactions with newer antipsychotics: a comparative reviewBasic Clin Pharmacol Toxicol2007100142217214606
   PubMed Web of Science ®Google Scholar
• DarbyJKPastaDJWilsonMGHerbertJLong-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic studyClin Drug Investig2008289553564
   PubMed Web of Science ®Google Scholar
• MarkowitzJSDeVaneCLMalcolmRJPharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteersJ Clin Pharmacol200646216417116432268
   PubMed Web of Science ®Google Scholar
• GrotheDRCalisKAJacobsenLOlanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophreniaJ Clin Psychopharmacol200020222022510770461
   PubMed Web of Science ®Google Scholar
• TheisenFMHaberhausenMSchulzESerum levels of olanzapine and its N-desmethyl and 2-hydroxymethyl metabolites in child and adolescent psychiatric disorders: effects of dose, diagnosis, age, sex, smoking, and comedicationTher Drug Monit200628675075917164690
   PubMed Web of Science ®Google Scholar
• BachmannCJHaberhausenMHeinzel-GutenbrunnerMRemschmidtHTheisenFMLarge intraindividual variability of olanzapine serum concentrations in adolescent patientsTher Drug Monit200830110811218223472
   PubMed Web of Science ®Google Scholar
• AichhornWMarksteinerJWalchTAge and gender effects on olanzapine and risperidone plasma concentrations in children and adolescentsJ Child Adolesc Psychopharmacol200717566567417979586
   PubMed Web of Science ®Google Scholar
• KumraSJacobsenLKLenaneMChildhood-onset schizophrenia: an open-label study of olanzapine in adolescentsJ Am Acad Child Adolesc Psychiatry19983743773859549958
   PubMed Web of Science ®Google Scholar
• SholevarEHBaronDAHardieTLTreatment of childhood-onset schizophrenia with olanzapineJ Child Adolesc Psychopharmacol2000102697810933117
   PubMed Web of Science ®Google Scholar
• MozesTGreenbergYSpivakBTyanoSWeizmanAMesterROlanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label studyJ Child Adolesc Psychopharmacol200313331131714642019
   PubMed Web of Science ®Google Scholar
• ShawPSpornAGogtayNChildhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparisonArch Gen Psychiatry200663772173016818861
   PubMed Web of Science ®Google Scholar
• KumraSKranzlerHGerbino-RosenGClozapine and “high-dose” olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparisonBiol Psychiatry200863552452917651705
   PubMed Web of Science ®Google Scholar
• FindlingRLMcNamaraNKYoungstromEABranickyLADemeterCASchulzSCA prospective, open-label trial of olanzapine in adolescents with schizophreniaJ Am Acad Child Adolesc Psychiatry200342217017512544176
   PubMed Web of Science ®Google Scholar
• RossRGNovinsDFarleyGKAdlerLEA 1-year open-label trial of olanzapine in school-age children with schizophreniaJ Child Adolesc Psychopharmacol200313330130914642018
   PubMed Web of Science ®Google Scholar
• QuintanaHWilsonMS2ndPurnellWLaymanAKMercanteDAn open-label study of olanzapine in children and adolescents with schizophreniaJ Psychiatr Pract2007132869617414684
   PubMedGoogle Scholar
• DittmannRWMeyerEFreislederFJEffectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label studyJ Child Adolesc Psychopharmacol2008181546918294089
   PubMed Web of Science ®Google Scholar
• GothelfDApterAReidmanJOlanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophreniaJ Neural Transm2003110554556012721815
   PubMed Web of Science ®Google Scholar
• Castro-FornielesJParelladaMSoutulloCAAntipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approachJ Child Adolesc Psychopharmacol200818432733618759642
   PubMed Web of Science ®Google Scholar
• FindlingRJohnsonJMcClellanJDouble-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum Study (TEOSS)J Am Acad Child Adolesc Psychiatry201049658359420494268
   PubMed Web of Science ®Google Scholar
• KryzhanovskayaLSchulzSCMcDougleCOlanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trialJ Am Acad Child Adolesc Psychiatry2009481607019057413
   PubMed Web of Science ®Google Scholar
• OverallJEPfefferbaumBThe Brief Psychiatric Rating Scale for ChildrenPsychopharmacol Bull19821821016 1978; 133:429–4357111598
   PubMedGoogle Scholar
• HughesCWRintelmannJEmslieGJLopezMMacCabeNA revised anchored version of the BPRS-C for childhood psychiatric disordersJ Child Adolesc PsychopharmacolSpring20011117793
   Web of Science ®Google Scholar
• LaughrenTMemorandum on recommendation for approvable actions for Zyprexa Pediatric Supplements for bipolar disorder (acute mania) and schizophrenia. [pdf from website]4292007 Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApproval-Process/DevelopmentResources/UCM163360.pdf. Published 2010Accessed Feb 10, 2010
   Google Scholar
• YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry1978133429435728692
   PubMed Web of Science ®Google Scholar
• DelBelloMPCecilKMAdlerCMDanielsJPStrakowskiSMNeurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy studyNeuropsychopharmacology20063161264127316292323
   PubMed Web of Science ®Google Scholar
• WoodsSWMartinASpectorSGMcGlashanTHEffects of development on olanzapine-associated adverse eventsJ Am Acad Child Adolesc Psychiatry200241121439144612447030
   PubMed Web of Science ®Google Scholar
• KryzhanovskayaLARobertson-PlouchCKXuWCarlsonJLMeridaKMDittmannRWThe safety of olanzapine in adolescents with schizophrenia or bipolar I disorder: a pooled analysis of 4 clinical trialsJ Clin Psychiatry200970224725819210948
   PubMed Web of Science ®Google Scholar
• RatzoniGGothelfDBrand-GothelfAWeight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective studyJ Am Acad Child Adolesc Psychiatry200241333734311886029
   PubMed Web of Science ®Google Scholar
• MozesTEbertTMichalSESpivakBWeizmanAAn open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophreniaJ Child Adolesc Psychopharmacol200616439340316958565
   PubMed Web of Science ®Google Scholar
• FleischhakerCHeiserPHennighausenKWeight gain associated with clozapine, olanzapine and risperidone in children and adolescentsJ Neural Transm2007114227328017109073
   PubMed Web of Science ®Google Scholar
• FleischhakerCHeiserPHennighausenKWeight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidoneJ Neural Transm2008115111599160818779922
   PubMed Web of Science ®Google Scholar
• CorrellCUManuPOlshanskiyVNapolitanoBKaneJMMalhotraAKCardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescentsJAMA2009302161765177319861668
   PubMed Web of Science ®Google Scholar
• GebhardtSHaberhausenMHeinzel-GutenbrunnerMAntipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight courseJ Psychiatr Res200943662062619110264
   PubMed Web of Science ®Google Scholar
• DomonSEWebberJCHyperglycemia and hypertriglyceridemia secondary to olanzapineJ Child Adolesc Psychopharmacol200111328528811642478
   PubMed Web of Science ®Google Scholar
• SelvaKAScottSMDiabetic ketoacidosis associated with olanzapine in an adolescent patientJ Pediatr2001138693693811391346
   PubMed Web of Science ®Google Scholar
• BlochYVardiOMendlovicSLevkovitzYGothelfDRatzoniGHyperglycemia from olanzapine treatment in adolescentsJ Child Adolesc Psychopharmacol20031319710212804130
   PubMed Web of Science ®Google Scholar
• CourvoisieHECookeDWRiddleMAOlanzapine-induced diabetes in a seven-year-old boyJ Child Adolesc Psychopharmacol200414461261615662154
   PubMed Web of Science ®Google Scholar
• Gonzalez-HeydrichJRachesDWilensTELeichtnerAMezzacappaERetrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combinationJ Am Acad Child Adolesc Psychiatry200342101227123314560173
   PubMed Web of Science ®Google Scholar
• WudarskyMNicolsonRHamburgerSDElevated prolactin in pediatric patients on typical and atypical antipsychoticsJ Child Adolesc Psychopharmacol19999423924510630453
   PubMed Web of Science ®Google Scholar
• AlfaroCLWudarskyMNicolsonRCorrelation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapineJ Child Adolesc Psychopharmacol2002122839112188977
   PubMed Web of Science ®Google Scholar
• KumraSJacobsenLKLenaneMCase series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophreniaJ Am Acad Child Adolesc Psychiatry19983722212279473920
   PubMed Web of Science ®Google Scholar
• PicardLSLindsaySStrawnJRKaneriaRMPatelNCKeckPEJrAtypical neuroleptic malignant syndrome: diagnostic controversies and considerationsPharmacotherapy200828453053518363536
   PubMed Web of Science ®Google Scholar
• NeuhutRLindenmayerJPSilvaRNeuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a reviewJ Child Adolesc Psychopharmacol200919441542219702493
   PubMed Web of Science ®Google Scholar
• Abu-KishkIToledanoMReisADanielDBerkovitchMNeuroleptic malignant syndrome in a child treated with an atypical antipsychoticJ Toxicol Clin Toxicol200442692192515533033
   PubMed Web of Science ®Google Scholar
• MendhekarDNDuggalHSPersistent amnesia as a sequel of olanzapine- induced neuroleptic malignant syndromeJ Neuropsychiatry Clin Neurosci200618455255317135384
   PubMed Web of Science ®Google Scholar
• CohenLGFataloAThompsonBTDi Centes BergeronGFloodJGPoupoloPROlanzapine overdose with serum concentrationsAnn Emerg Med199934227527810424935
   PubMed Web of Science ®Google Scholar
• CroarkinPEEmslieGJMayesTLNeuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published casesJ Clin Psychiatry20086971157116518572981
   PubMed Web of Science ®Google Scholar
• DelieuJMHorobinRWDuguidJKExploring the relationship of drug-induced neutrophil immaturity and haematological toxicity to drug chemistry using quantitative structure-activity modelsMed Chem20095171419149645
   PubMed Web of Science ®Google Scholar
• StubnerSGrohmannREngelRBlood dyscrasias induced by psychotropic drugsPharmacopsychiatry200437Suppl 1S707815052517
   PubMed Web of Science ®Google Scholar
• ElianAAFatal overdose of olanzepineForensic Sci Int19989132312359530833
   PubMed Web of Science ®Google Scholar
• GerberJECawthonBOverdose and death with olanzapine: two case reportsAm J Forensic Med Pathol200021324925110990286
   PubMed Web of Science ®Google Scholar
• ChuePSingerPA review of olanzapine-associated toxicity and fatality in overdoseJ Psychiatry Neurosci200328425326112921220
   PubMed Web of Science ®Google Scholar
• AntiaSXSholevarEHBaronDAOverdoses and ingestions of second-generation antipsychotics in children and adolescentsJ Child Adolesc Psychopharmacol200515697098516379518
   PubMed Web of Science ®Google Scholar
• ChambersRACaracansiAWeissGOlanzapine overdose cause of acute extrapyramidal symptomsAm J Psychiatry199815511163016319812139
   PubMed Web of Science ®Google Scholar
• CatalanoGCooperDSCatalanoMCButeraASOlanzapine overdose in an 18-month-old childJ Child Adolesc Psychopharmacol19999426727110630456
   PubMed Web of Science ®Google Scholar
• KochharSNwokikeJNJankowitzBSholevarEHAbedTBaronDAOlanzapine overdose: a pediatric case reportJ Child Adolesc Psychopharmacol200212435135312625996
   PubMed Web of Science ®Google Scholar
• TheisenFMGrabarkiewiczJFegbeutelCHubnerAMehler-WexCRemschmidtHOlanzapine overdose in children and adolescents: two case reports and a review of the literatureJ Child Adolesc Psychopharmacol200515698699516379519
   PubMed Web of Science ®Google Scholar
• CooperWOHicksonGBFuchsCArbogastPGRayWANew users of antipsychotic medications among children enrolled in TennCareArch Pediatr Adolesc Med2004158875375915289247
   PubMedGoogle Scholar
• AparasuRRBhataraVAntipsychotic prescribing trends among youths, 1997–2002Psychiatr Serv200556890416088004
   PubMed Web of Science ®Google Scholar
• PatelNCCrismonMLHoagwoodKTrends in the use of typical and atypical antipsychotics in children and adolescentsJ Am Acad Child Adolesc Psychiatry200544654855615908837
   PubMed Web of Science ®Google Scholar
• CooperWOArbogastPGDingHHicksonGBFuchsDCRayWATrends in prescribing of antipsychotic medications for US childrenAmbul Pediatr200662798316530143
   PubMedGoogle Scholar
• OlfsonMBlancoCLiuLMorenoCLajeGNational trends in the outpatient treatment of children and adolescents with antipsychotic drugsArch Gen Psychiatry200663667968516754841
   PubMed Web of Science ®Google Scholar
• AparasuRRBhataraVPatterns and determinants of antipsychotic prescribing in children and adolescents, 2003–2004Curr Med Res Opin2007231495617257465
   PubMed Web of Science ®Google Scholar
• Alessi-SeveriniSBiscontriRGCollinsDMKozyrskyjASareenJEnnsMWUtilization and costs of antipsychotic agents: a Canadian population-based study, 1996–2006Psychiatr Serv200859554755318451015
   PubMed Web of Science ®Google Scholar
• ConstantineRTandonRChanging trends in pediatric antipsychotic use in Florida’s Medicaid programPsychiatr Serv200859101162116818832502
   PubMed Web of Science ®Google Scholar
• RaniFMurrayMLByrnePJWongICEpidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United KingdomPediatrics200812151002100918450906
   PubMed Web of Science ®Google Scholar
• LiebermanJATollefsonGDCharlesCAntipsychotic drug effects on brain morphology in first-episode psychosisArch Gen Psychiatry200562436137015809403
   PubMed Web of Science ®Google Scholar
• PotterMPLiuHYMonuteauxMCPrescribing patterns for treatment of pediatric bipolar disorder in a specialty clinicJ Child Adolesc Psychopharmacol200919552953819877977
   PubMed Web of Science ®Google Scholar